FdaApplication
ANDA 201921
Identifiers
- fda_app_no: ANDA201921
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2012-12-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LANSOPRAZOLE | LANSOPRAZOLE | 15MG | CAPSULE, DELAYED REL PELLETS;ORAL |
| LANSOPRAZOLE | LANSOPRAZOLE | 30MG | CAPSULE, DELAYED REL PELLETS;ORAL |
2 products